Comparison of Obturator Nerve Block With Ultrasound Guidance and Anatomical Signs
1 other identifier
interventional
116
1 country
1
Brief Summary
Comparison of the obturator nerve block in patients undergoing transurethral resection due to bladder tumor, technically using ultrasound guided or blinded with anatomical signs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 16, 2020
CompletedFirst Posted
Study publicly available on registry
November 20, 2020
CompletedStudy Start
First participant enrolled
February 16, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2022
CompletedFebruary 7, 2022
January 1, 2022
1 year
November 16, 2020
January 24, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Preoperative succesful obturator nerve block
peroperative adductor muscle spazm
operation time
Secondary Outcomes (1)
peroperative bleeding, Presence of recurrent tumor at postoperative 3rd month
3 months
Study Arms (2)
Ultrasound-guided obturator nerve block group
ACTIVE COMPARATORThe ultrasound probe will be placed in the middle of the tuberculum pubis and femoral artery, 5-6 cm below the inguinal ligament, and 5 mL of 0.5% bupivacaine will be injected into the anterior and posterior branches of the ON with a needle.
obtutaror nerve block with anatomical landmarks
ACTIVE COMPARATORIn the second group, after the patient is placed in the lithotomy position, 1.5 cm lateral tuberculum pubis and 1.5 cm caudal will be marked and needle entry will be made and 0.5% bupivacaine will be injected with 10 mL.
Interventions
The ultrasound probe will be placed in the middle of the tuberculum pubis and femoral artery, 5-6 cm below the inguinal ligament, and 5 mL of 0.5% bupivacaine will be injected into the anterior and posterior branches of the ON with a needle. In the second group, after the patient is placed in the lithotomy position, 1.5 cm lateral tuberculum pubis and 1.5 cm caudal will be marked and needle entry will be made and 0.5% bupivacaine will be injected with 10 mL. The time elapsed until the first needle insertion and local anesthetic injection is completed will be recorded as the application time.
Eligibility Criteria
You may qualify if:
- ASA I-II patients
You may not qualify if:
- Tumors that disrupt the integrity of the bladder,
- bladder floor tumors,
- coagulation disorders,
- motor in the lower limbs
- with sensory disturbances,
- uncooperative patients,
- Known allergy to local anesthetics
- patients with localized infection at the procedure site
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mugla Sitki Kocman University
Muğla, 48000, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eylem Yaşar
Muğla Sıtkı Koçman University
- STUDY CHAIR
Ali İhsan Uysal
Mugla Sitki Kocman University Department of Anesthesia
- STUDY CHAIR
İlker Akarken
Mugla Sitki Kocman University Department of Urology
- STUDY CHAIR
basak altiparmak
Mugla Sitki Kocman University Department of Anesthesia
- STUDY CHAIR
semra demirbilek
Mugla Sitki Kocman University Department of Anesthesia
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- medical doctor of anesthesiology special
Study Record Dates
First Submitted
November 16, 2020
First Posted
November 20, 2020
Study Start
February 16, 2021
Primary Completion
March 1, 2022
Study Completion
September 1, 2022
Last Updated
February 7, 2022
Record last verified: 2022-01
Data Sharing
- IPD Sharing
- Will not share